XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current assets    
Cash $ 868,692
Prepaid expenses and other current asset 496,414
Total Current Assets 1,365,106
Deferred offering costs 164,899
Cash and marketable securities held in Trust Account 253,019,504
TOTAL ASSETS 254,384,610 164,899
Current liabilities    
Accrued expenses 215,609 675
Accrued offering costs 12,000 99,899
Due to Sponsor 16,152
Promissory note – related party 40,000
Total Current Liabilities 243,761 140,574
Warrant liabilities 10,643,400
Deferred underwriting fee payable 8,855,000
Total Liabilities 19,742,161 140,574
Commitments and contingencies
Class A common stock subject to possible redemption 22,964,245 and no shares at $10.00 per share redemption value at June 30, 2021 and December 31, 2020, respectively 229,642,450
Stockholders’ Equity    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Class A common stock, $0.0001 par value; 80,000,000 shares authorized; 2,335,755 and no shares issued and outstanding (excluding 22,964,245 and no shares subject to possible redemption) at June 30, 2021 and December 31, 2020, respectively [1] 234
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,325,000 shares issued and outstanding at June 30, 2021 and December 31, 2020 [1] 633 633
Additional paid-in capital 4,680,839 24,367
Retained Earnings (Accumulated deficit) 318,293 (675)
Total Stockholders’ Equity 4,999,999 24,325
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 254,384,610 $ 164,899
[1] At December 31, 2020, included up to 825,000 shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 5).